The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2026 | Airborne carcinogen exposure and lung cancer risk in urban Rhode Island
Hina Khan, MD, Brown University, Providence, RI, discusses neighborhood-level fine particulate matter (PM2.5) exposure across Providence, Rhode Island, measured by the Breathe Providence Project, and its potential link to the state’s elevated lung cancer incidence. Although annual averages were near World Health Organization guidelines at some sites, daily limits were exceeded far more often than recommended, particularly during summer months, possibly reflecting wildfire activity. This interview took place at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
